wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33414632-CE133679-38E2-40E2-AF5B-374CE14FDFFC
Q33414632-CE133679-38E2-40E2-AF5B-374CE14FDFFC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33414632-CE133679-38E2-40E2-AF5B-374CE14FDFFC
A phase I dose escalation study of oral c-MET inhibitor tivantinib (ARQ 197) in combination with gemcitabine in patients with solid tumors.
P2860
Q33414632-CE133679-38E2-40E2-AF5B-374CE14FDFFC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33414632-CE133679-38E2-40E2-AF5B-374CE14FDFFC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e52093b6d7da330aeb190a9be1dc362722d8f7d8
P2860
c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases.